SCHEMBL2018774

SCHEMBL2018774

CC1(CNCCc2ccccc2)CC1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRM2 P08172 1/20 0.51
CHRM1 P11229 1/20 0.51
CHRM3 P20309 1/20 0.51
SIGMAR1 Q99720 7/20 0.50
GAA P10253 2/20 0.50
MAPT P10636 1/20 0.50
ATM Q13315 1/20 0.48
TAAR1 Q96RJ0 1/20 0.48
KCNH2 Q12809 2/20 0.44
CYP3A4 P08684 2/20 0.44
CYP2D6 P10635 2/20 0.44
CYP2C19 P33261 2/20 0.44
NPC1 O15118 1/20 0.44
KDM1A O60341 1/20 0.44
ALDH1A1 P00352 1/20 0.44
LMNA P02545 1/20 0.44
CYP1A2 P05177 1/20 0.44
HTR1A P08908 1/20 0.44
ADRA2A P08913 1/20 0.44
CYP2C8 P10632 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2019716 0.81 MEN1 (0.50) CHRM2SIGMAR1GAAMAPTCYP3A4
Hydrochloric Acid SCHEMBL27690675 0.79 MEN1 (0.48) CHRM2SIGMAR1GAAMAPTCYP3A4
SCHEMBL13716233 0.79 CHRM2 (0.41) CHRM2CHRM1CHRM3SIGMAR1GAA
SCHEMBL13716338 0.78 GRIN2B (0.46) CHRM2CHRM1CHRM3SIGMAR1GAA
SCHEMBL283735 0.75 SIGMAR1 (0.81) SIGMAR1GAAMAPTATMTAAR1
SCHEMBL23023065 0.73 MEN1 (0.45) CHRM2SIGMAR1GAAMAPTCYP3A4
SCHEMBL8140699 0.73 SIGMAR1 (0.77) SIGMAR1GAAMAPTATMTAAR1
Hydrochloric Acid SCHEMBL5028920 0.73 SIGMAR1 (0.77) SIGMAR1GAAMAPTATMTAAR1
SCHEMBL13937400 0.73 SIGMAR1 (0.77) SIGMAR1GAAMAPTATMTAAR1
SCHEMBL1406143 0.71 SIGMAR1 (0.64) SIGMAR1GAAMAPTATMTAAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7968571-B2 2,4,6-substituted pyridyl derivative compounds useful as beta-secretase inhibitors for the treatment of Alzheimer's Disease Merck, Sharp & Dohme, Corp. (US) 2011-06-28 US disclosed